mPATH Health
7 known investors
mPATH is a digital patient navigation platform that automates cancer screening outreach, eligibility verification, decision support, and completion tracking for health systems, working alongside existing EHRs without integration. It targets healthcare providers seeking to improve screening completion rates, HEDIS/Stars quality scores, and value-based contract performance.
Investors · 7
Oncology VenturesNew Yorkvia Ben Freeberg · inferred
Atlanta Technology Angelsreported · 2 sourcesAtlanta · $200K – $2M
First Launch CapitalreportedGreensboro
VentureSouthreportedGreenville
Also in the syndicate · 3
FCP VenturesRTP Angel FundWinston-Salem Partners Roundtable (WSPR) Fundlead
Funding
SEC filings, press & company announcements$1.1M disclosed across 1 round · 2024
- $1.1MraisedMar 2024 · 2 sources
Winston-Salem Partners Roundtable (WSPR) Fund (lead), Atlanta Technology Angels, FCP Ventures, First Launch Capital, RTP Angel Fund, VentureSouth
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does mPATH Health do?
- mPATH is a digital patient navigation platform that automates cancer screening outreach, eligibility verification, decision support, and completion tracking for health systems, working alongside existing EHRs without integration. It targets healthcare providers seeking to improve screening completion rates, HEDIS/Stars quality scores, and value-based contract performance.
- Who are mPATH Health's investors?
- mPATH Health's investors include Oncology Ventures, Atlanta Technology Angels, First Launch Capital, VentureSouth.
- How much funding has mPATH Health raised?
- mPATH Health has disclosed $1.1M raised across 1 round.